Home » Topics » BioWorld

BioWorld
RSS

PATENT COVERS FIBRINOGEN MAb

Feb. 26, 1992

SOMATIX PATENT SUFFERS SETBACK

Feb. 26, 1992

MEDICIS WARRANT REDEMPTION RAISES $14M

Feb. 25, 1992

MYCOGEN ADOPTS POISON PILL

Feb. 25, 1992

SOMATOGEN BLOOD SUBSTITUTE ENTERS TRIALS

Feb. 25, 1992

ICOS BACK TO THE FUNDING WELL

Feb. 25, 1992

GRANT FOR DNA IDENTIFICATION SYSTEM

Feb. 25, 1992

MGI FILES FOR SALAGEN APPROVAL

Feb. 25, 1992

RISK POLICY PAVES WAY FOR BIOTECH RULES

Feb. 25, 1992

TSI SHARES ELIGIBLE FOR CONVERSION

Feb. 25, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...